who shouldn't take glp-1 should not a glp 1 The promise and peril of agonists: What Wait - Maybe You Should

Renal outcomes in the EXenatide study of cardiovascular event lowering (EXSCEL)

These thresholds may vary by ethnicity, with lower cutoffs for certain populations, particularly those of Asian descent

While this is usually a positive effect, such as reducing inflammation in blood vessels or other tissues, in rare cases, it might trigger localized inflammation in muscles or joints, which could lead to discomfort or stiffness in the neck

Some patients may also benefit from blood work or muscle mass screening before starting a GLP-1

Our commitment to transparent service means our approach remains consistent, irrespective of dosage changes